PMV Pharmaceuticals is a precision oncology company focused on developing small molecule therapies for p53 mutations in cancer. Their lead product candidate, PC14586, corrects a specific p53 mutation and restores normal function. They are also working on other p53 mutations. The company was founded in 2013 and is based in Cranbury, New Jersey.